31.18
price down icon2.13%   -0.68
after-market Handel nachbörslich: 31.79 0.61 +1.96%
loading

Ultragenyx Pharmaceutical Inc Aktie (RARE) Neueste Nachrichten

pulisher
10:37 AM

Is Ultragenyx Pharmaceutical Inc. (UP0) stock a defensive play amid uncertaintyPortfolio Profit Report & Trade Opportunity Analysis - newser.com

10:37 AM
pulisher
05:27 AM

Will Ultragenyx Pharmaceutical Inc. stock reach all time highs in 20252025 AllTime Highs & Growth Focused Entry Reports - newser.com

05:27 AM
pulisher
03:35 AM

Can Ultragenyx Pharmaceutical Inc. stock maintain operating margins2025 EndofYear Setup & Verified Chart Pattern Signals - newser.com

03:35 AM
pulisher
Nov 19, 2025

Why Ultragenyx Pharmaceutical Inc. stock remains on watchlistsQuarterly Portfolio Review & AI Powered Trade Plan Recommendations - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Key metrics from Ultragenyx Pharmaceutical Inc.’s quarterly dataJuly 2025 Big Picture & Low Risk High Win Rate Stock Picks - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

OMERS increases stake in Ultragenyx’s rare disease drug revenues - Canadian Lawyer Mag

Nov 19, 2025
pulisher
Nov 19, 2025

Is Ultragenyx Pharmaceutical Inc. stock a top momentum playTake Profit & Risk Adjusted Buy and Sell Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Can Ultragenyx Pharmaceutical Inc. rally from current levelsAnalyst Downgrade & Expert Curated Trade Setups - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Ultragenyx Pharmaceutical Inc. still worth holding after the dipStop Loss & Weekly Sector Rotation Insights - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will Ultragenyx Pharmaceutical Inc. stock gain from government policiesPortfolio Performance Report & Reliable Entry Point Trade Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is this a good reentry point in Ultragenyx Pharmaceutical Inc.Weekly Volume Report & Daily Profit Focused Screening - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Is it too late to sell Ultragenyx Pharmaceutical Inc.IPO Watch & Risk Managed Investment Strategies - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

Ultragenyx Signs $400M Royalty Purchase Agreement - MSN

Nov 18, 2025
pulisher
Nov 18, 2025

Campbell & CO Investment Adviser LLC Makes New $309,000 Investment in Ultragenyx Pharmaceutical Inc. $RARE - MarketBeat

Nov 18, 2025
pulisher
Nov 17, 2025

Bank of New York Mellon Corp Cuts Stock Holdings in Ultragenyx Pharmaceutical Inc. $RARE - MarketBeat

Nov 17, 2025
pulisher
Nov 16, 2025

Is Ultragenyx Pharmaceutical Inc. stock attractive for long term wealth buildingWeekly Risk Summary & Weekly Setup with High ROI Potential - newser.com

Nov 16, 2025
pulisher
Nov 15, 2025

Is Ultragenyx Pharmaceutical Inc. stock attractive after correction2025 Valuation Update & Fast Exit Strategy with Risk Control - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Can Ultragenyx Pharmaceutical Inc. stock sustain revenue growth2025 Fundamental Recap & Real-Time Market Sentiment Alerts - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Earnings visualization tools for Ultragenyx Pharmaceutical Inc.2025 Volatility Report & Long-Term Growth Stock Strategies - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Ultragenyx Pharmaceutical Inc. $RARE Holdings Lowered by Candriam S.C.A. - MarketBeat

Nov 15, 2025
$38.39
price down icon 0.67%
$30.04
price down icon 1.73%
$101.76
price up icon 0.43%
$96.97
price down icon 4.40%
biotechnology ONC
$349.29
price down icon 1.27%
$199.64
price down icon 1.93%
Kapitalisierung:     |  Volumen (24h):